Delivery Order SPE2DB20D3103-SPE2DB25FP7V3
- Not listed
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 13, 2025, for the supply of Jardiance 25 mg tablets (90-count packages) valued at $10,494.63. The contract is a firm fixed price delivery order with no set-aside designation, indicating competitive award. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, is a major pharmaceutical distributor serving federal medical procurement needs, particularly for military and veteran...
- The Defense Logistics Agency awarded a $11,502.77 delivery order to AmerisourceBergen Drug Corp on June 18, 2025, for the supply of Jardiance 10 mg tablets (90-count package), with a completion date of June 20, 2025. This contract was competitively awarded with no set-aside designation and operates under a firm fixed-price structure. The work will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is a child contract issued under...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on September 3, 2025, for the supply of Jardiance 25 mg tablets (90-count packages) valued at $18,509.94 under a firm fixed-price contract. This is a non-set-aside competitive award executed at the company's Conshohocken, Pennsylvania facility. The delivery order represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX and...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for the supply of Jardiance 25 mg tablets (90-count) under a firm fixed price contract valued at $22,704.73, with an ultimate completion date of July 9, 2025. This non-set-aside delivery order represents a competitive award to the major pharmaceutical distributor, which maintains its corporate office in Conshohocken, Pennsylvania. The contract falls under AmerisourceBergen's larger indefinite delivery contract...
- The Defense Logistics Agency awarded a delivery order valued at $4,158.66 to AmerisourceBergen Drug Corp for the supply of Jardiance 10 mg tablets (90-count) on August 21, 2025, with completion anticipated by August 22, 2025. This non-set-aside, competitively awarded contract utilizes firm fixed pricing and is being performed at the contractor's facility in Conshohocken, Pennsylvania. The delivery order is issued under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA...
- The Defense Logistics Agency awarded a delivery order valued at $37,169.95 to AmerisourceBergen Drug Corp for the supply of Jardiance 25 mg tablets (90-count) on September 10, 2025, with completion targeted for September 11, 2025. The contract employs firm fixed-price pricing with no set-aside designation, indicating competitive award. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, will perform the work at its corporate office location. This delivery order is issued...
- The Defense Logistics Agency awarded a delivery order valued at $22,670.24 to AmerisourceBergen Drug Corp for the supply of Jardiance 25 mg tablets (90-count units) on June 12, 2025, with a completion date of June 13, 2025. This competitively awarded, non-set-aside contract utilizes firm fixed pricing and designates AmerisourceBergen's Conshohocken, Pennsylvania location as the place of performance. The delivery order is issued under AmerisourceBergen's larger Indefinite Delivery Contract with...
- The Defense Logistics Agency awarded a $3,018.22 firm fixed-price delivery order to AmerisourceBergen Drug Corp on August 14, 2025, for the supply of Jardiance 25 mg tablets (90-count units). The contract, which is not set-aside, will be performed at the vendor's corporate office location in Conshohocken, Pennsylvania, with an ultimate completion date of August 15, 2025. This delivery order is a child contract issued under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $3,715.58 to AmerisourceBergen Drug Corp for the supply of Jardiance 10 mg tablets in a 90-count quantity. The contract was awarded on April 28, 2025, with an ultimate completion date of April 29, 2025, using firm fixed-price pricing with no set-aside designation. The place of performance is listed as AmerisourceBergen's corporate office in Conshohocken, Pennsylvania. This delivery order represents a child contract issued...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 27, 2025, for the supply of Jardiance 10 mg tablets in quantities of 90 units. This competitively awarded contract, valued at $34,528.08, represents a firm fixed-price delivery order with performance completion scheduled for August 28, 2025. The order will be fulfilled from AmerisourceBergen's location in Conshohocken, Pennsylvania, and carries no set-aside designation. This delivery order is...
- SPE2DB20D3103Indefinite Delivery Contract
- SPE2DB20D3103-SPE2DB25FP7V3Delivery Order
The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, for the supply of Jardiance 25 mg tablets (90-count supply). This firm fixed-price delivery order, valued at $8,515.11, was awarded on August 7, 2025, with an ultimate completion date of August 8, 2025. The contract represents a non-competitive, non-set-aside award and will be performed at the vendor's corporate office location in Conshohocken, PA. This delivery order is a child contract issued under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX and valued at $999,999,999.00 through December 2026. AmerisourceBergen Drug Corp serves as a critical vendor within the Defense Logistics Agency's Medical Supply Chain, delivering a comprehensive range of pharmaceutical products and medical supplies to support military and veteran healthcare systems. The company holds significant authority to fulfill federal medical procurement across multiple therapeutic domains, including diabetes medications, neurological treatments, pain management pharmaceuticals, and specialized medical supplies. This particular delivery order for Jardiance, a diabetes medication, exemplifies the company's role in supplying essential brand-name pharmaceutical commodities to support military healthcare operations. The vendor's extensive federal contract portfolio and competitive performance history demonstrate its capability to meet stringent federal procurement standards and delivery timelines.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $8.5k | 8/7/25 |